Search

everythinglearnresearchcommunity

for

Search:↓

Toxic Shock Syndrome cases increased due to new factors, but decreased with public health measures and changes in tampon use.

Mood stabilizers like lithium and anticonvulsants have side effects that can lead to patients stopping their medication, and managing these effects is important for treatment adherence.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

SHBG may be a useful early indicator and treatment target for PCOS.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Minoxidil 2% effectively treats female hair loss, promoting growth and density.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Hair loss in women not always linked to increased oil production; other factors may be involved.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

The document concludes that using specific tools and tests is essential for identifying the cause of hair loss and deciding on the right treatment.

Herbal products might promote hair growth with fewer side effects, but more research is needed to confirm their safety and effectiveness.

Phototrichogram and hair diameter measurements are effective, noninvasive ways to assess hair growth and detect early hair loss, with the most common pattern being reduced hair density.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Quick treatment of hair disorders in teenage girls is important because of the emotional effects.

Sexual orientation does not affect the prevalence of PCOS or fertility rates in women undergoing artificial donor insemination.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Lifestyle changes are the first step in treating infertility in PCOS, followed by medications like clomiphene and metformin, and then surgery if needed.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.